Dossier
Seaport Therapeutics Inc.
Coverage of Seaport Therapeutics Inc. in the Nexus archive.
- Drugmaker Seaport Climbs 17% After $255 Million Upsized US IPO
Seaport Therapeutics Inc. shares rose 17% during their trading debut after the company raised $255 million through an upsized initial public offering in the US.